Bob Lederer RFL Communications, Inc.

Google Glass’ privacy problem; Online community startup tips (RBDR–4/09/2014)

Sponsored by Socratic Technologies (http://www.sotech.com), whose proprietary tools and methodologies tackle marketing complexities so the you can make more confident business decisions.

Today: 1) Google has been roundly praised for its targeting release of Google Glass to many individuals for testing purposes. However, out of nowhere, a consumer concern over privacy has emerged. 2) Toluna VP Online Communities Julie Paul tells RBDR some basics of her research specialty, including startup costs, what to focus on and more.

Bob Lederer RFL Communications, Inc.

Study shows why brands can not afford to ignore customer social media complaints; Eric Salama, Part 2: the likely major change in MR this year (RBDR–4/8/2014)

Sponsored by Socratic Technologies (http://www.sotech.com), whose proprietary tools and methodologies tackle marketing complexities so the you can make more confident business decisions.

Today: 1) Two studies RBDR noted last week shows fewer of the fastest growing companies are paying attention to customer complaints on Twitter. Now, a new study shows the peril those companies may be put themselves in because consumers base their purchasing decisions on their brand interactions, and bad experiences need to be dealt with. 2) Part 2 of RBDR’s conversation with Kantar CEO Eric Salama. Hear what he thinks is the likely THE major development in research in 2014, plus a new way of considering respondents’ interests.

Bob Lederer RFL Communications, Inc.

Biotech’s 1st Chief Patient Officer; ACA boosts Medicaid Rx spend (PRVR–4/7 to 4/11/2014)

This week on Pharma Research VIDEO Report: 1) Pharmaceutical companies have cut back on what they pay physicians to speak on their behalf, but the real attention getter will be the searchable database patients will be able to access with 2013 data on pharmacy spending of $10 or more with each U.S. doctor. 2) Sanofi breaks new industry ground by appointing the first Chief Patient Officer. 3) Charlotte Sibley returns to recommend three steps that pharmaceutical companies can take with their research departments to implement Big Data opportunities. 4) With the ACA’s 2014 enrollment period in the past, the first reports of its impact on the pharmaceutical industry are being released.

Bob Lederer RFL Communications, Inc.

vitaTrackr: Let’s create data-enabled healthcare; IBM Watson battles cancer (PRVR–3/31/14)

This week on Pharma Research VIDEO Report:

1) Hats off to vitaTrackr, which has decided to take the lead by inviting key elements of the health care industry to join it in a collaboration to create the foundation for data-enabled health care. 2) IBM Watson is being assigned its most challenging task to date: helping to find medical cures for glioblastoma patients. 3) Pharma MR stalwart and proponent Charlotte Sibley speaks with Bob Lederer about how and why many pharmacos are missing the boat with Big Data. 4) The Ogilvy Awards handed out at the ARF ReThink Conference awarded 6 different health care-related organizations in a New York ceremony on March 25.

Bob Lederer RFL Communications, Inc.

ONLY 11% of marketing decisions use data; Kantar’s Eric Salama joins RBDR (RBDR–4/7/2014)

Sponsored by Socratic Technologies (http://www.sotech.com), whose proprietary tools and methodologies tackle marketing complexities so the you can make more confident business decisions.

Today: 1) An August 2012 study says marketers make only 11% of their decisions using data, which is largely corroborated by 2014 research. There is bad and good in this shocking reality. 2) Kantar CEO Eric Salama discusses a handful of client-oriented research issues in the first of a two-party interview with RBDR’s Bob Lederer